_8Dq7PE1hzB28MQGuCvTvq.svg?width=1920&quality=80&format=auto)
Photo by Bhupathi Srinu on Unsplash
Clinical Trials
Research
PROTECT-TB
Completed
A Phase III, randomised, double blind, three arm placebo controlled trial to evaluate the efficacy and safety of two vaccines VPM1002 and Immuvac (Mw) in preventing Tuberculosis (TB) in healthy household contacts of newly diagnosed sputum positive pulmonary TB patients
The Indian Council of Medical Research (ICMR) the apex governing. body in India for the formulation, coordination and promotion of biomedical research selected SHARE INDIA and MediCiti Institute of Medical Sciences (MIMS) as s sub site of Bhagwan Mahavir Medical Research Center (MMMRC) for a vaccine study.
Photo by Prasesh Shiwakoti (Lomash) on Unsplash
Clinical Trials
Research
TOPSPIN
Completed
Treatment Optimisation for blood Pressure with Single-Pill combinations in India
Globally, high systolic blood pressure (SBP) was reported as the leading risk factor for morbidity and mortality. Hypertension is also a leading cause of death and disability in India with a prevalence of 30%. Significant variation was noted in hypertension prevalence among rural (28%) and urban (34%) patients in India.